Terms: = Liver cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS
282 results:
1. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
2. Time variation of high-risk groups for liver function deteriorations within fluctuating long-term liver function after hepatic radiotherapy in patients with hepatocellular carcinoma.
Tsai YL; Yu PC; Nien HH; Lu TP
Eur J Med Res; 2024 Feb; 29(1):104. PubMed ID: 38326881
[TBL] [Abstract] [Full Text] [Related]
3. [Successful Continuation of Treatment in Advanced Colorectal cancer by Switching to a Prior Biologic Agent after Emergence of Bevacizumab Allergy to a Biosimilar Drug-A Case Report].
Ushigome M; Funahashi K; Yoshida K; Okubo K; Miura Y; Suzuki T; Kagami S; Nagashima Y; Koda T; Kaneko T; Kurihara A; Mitsuda A
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1603-1605. PubMed ID: 38303355
[TBL] [Abstract] [Full Text] [Related]
4. Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various types of cancer.
Zhuang Y; Cai Q; Hu X; Huang H
BMC Endocr Disord; 2024 Jan; 24(1):9. PubMed ID: 38212751
[TBL] [Abstract] [Full Text] [Related]
5. Inactivated vaccines reduce the risk of liver function abnormality in NAFLD patients with COVID-19: a multi-center retrospective study.
Chen Z; Tang W; Feng N; Lv M; Meng F; Wu H; Zhao Y; Xu H; Dai Y; Xue J; Wang J; Xu A; Zhang B; Chu D; Li Y; Wu D; Dong L; Zhang S; Xue R
EBioMedicine; 2024 Jan; 99():104912. PubMed ID: 38096688
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors and novel nomograms for overall survival and cancer specific survival of malignant ovarian cancer patients with bone metastasis: A SEER-based study.
Luo L; Xu N; Liu Y; Zhong S; Yang S; Chen X
Int J Gynaecol Obstet; 2024 Apr; 165(1):176-187. PubMed ID: 38013509
[TBL] [Abstract] [Full Text] [Related]
7. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Zeng Q; Klein C; Caruso S; Maille P; Allende DS; Mínguez B; Iavarone M; Ningarhari M; Casadei-Gardini A; Pedica F; Rimini M; Perbellini R; Boulagnon-Rombi C; Heurgué A; Maggioni M; Rela M; Vij M; Baulande S; Legoix P; Lameiras S; ; Bruges L; Gnemmi V; Nault JC; Campani C; Rhee H; Park YN; Iñarrairaegui M; Garcia-Porrero G; Argemi J; Sangro B; D'Alessio A; Scheiner B; Pinato DJ; Pinter M; Paradis V; Beaufrère A; Peter S; Rimassa L; Di Tommaso L; Vogel A; Michalak S; Boursier J; Loménie N; Ziol M; Calderaro J
Lancet Oncol; 2023 Dec; 24(12):1411-1422. PubMed ID: 37951222
[TBL] [Abstract] [Full Text] [Related]
8. Beta-blocker use and survival after pancreatic cancer surgery: A nationwide population-based cohort study.
Kirkegård J; Cronin-Fenton D; Lund A; Mortensen FV
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5726. PubMed ID: 37946571
[TBL] [Abstract] [Full Text] [Related]
9. Multi-scale context UNet-like network with redesigned skip connections for medical image segmentation.
Qian L; Wen C; Li Y; Hu Z; Zhou X; Xia X; Kim SH
Comput Methods Programs Biomed; 2024 Jan; 243():107885. PubMed ID: 37897988
[TBL] [Abstract] [Full Text] [Related]
10. The value of MRI in predicting hepatocellular carcinoma with cytokeratin 19 expression: a systematic review and meta-analysis.
Qin Q; Deng LP; Chen J; Ye Z; Wu YY; Yuan Y; Song B
Clin Radiol; 2023 Dec; 78(12):e975-e984. PubMed ID: 37783612
[TBL] [Abstract] [Full Text] [Related]
11. Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients.
Bittaye SO; Kambi A; Tekanyi MAI; Tamba S; Sanneh L; Sisawo MM; Jatta A; Fatty G; Jeng A; Jallow MS; Leigh O; Njie R
BMC Gastroenterol; 2023 Sep; 23(1):321. PubMed ID: 37730538
[TBL] [Abstract] [Full Text] [Related]
12. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
Serra-Burriel M; Juanola A; Serra-Burriel F; Thiele M; Graupera I; Pose E; Pera G; Grgurevic I; Caballeria L; Piano S; van Kleef L; Reichert M; Roulot D; Pericàs JM; Schattenberg JM; Tsochatztis EA; Guha IN; Garcia-Retortillo M; Hernández R; Hoyo J; Fuentes M; Expósito C; Martínez A; Such P; Madir A; Detlefsen S; Tonon M; Martini A; Ma AT; Pich J; Bonfill E; Juan M; Soria A; Carol M; Gratacós-Ginès J; Morillas RM; Toran P; Navarrete JM; Torrejón A; Fournier C; Llorca A; Arslanow A; de Koning HJ; Cucchietti F; Manns M; Newsome PN; Hernáez R; Allen A; Angeli P; de Knegt RJ; Karlsen TH; Galle P; Wong VW; Fabrellas N; Castera L; Krag A; Lammert F; Kamath PS; Ginès P;
Lancet; 2023 Sep; 402(10406):988-996. PubMed ID: 37572680
[TBL] [Abstract] [Full Text] [Related]
13. Nomograms for predicting overall survival in colorectal cancer patients with metastasis to the liver, lung, bone, and brain.
Wang H; Shan X; Zhang M; Qian K; Shen Z; Zhou W
Cancer Causes Control; 2023 Dec; 34(12):1059-1072. PubMed ID: 37486401
[TBL] [Abstract] [Full Text] [Related]
14. Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram.
Long H; Peng C; Ding H; Zheng Y; Zhou J; Chen W; Zhong X; Shi Y; Duan Y; Xie X; Kuang M; Xie X; Lin M
Eur Radiol; 2023 Nov; 33(11):7665-7674. PubMed ID: 37314474
[TBL] [Abstract] [Full Text] [Related]
15. Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis.
Liu H; Han CL; Tian BW; Ding ZN; Yang YF; Ma YL; Yang CC; Meng GX; Xue JS; Wang DX; Dong ZR; Chen ZQ; Hong JG; Li T
Expert Rev Gastroenterol Hepatol; 2023; 17(6):623-633. PubMed ID: 37148261
[TBL] [Abstract] [Full Text] [Related]
16. Development and validation of web-based prognostic nomograms for massive hepatocellular carcinoma (≥10 cm): A retrospective study based on the SEER database.
Huang G; Lin Q; Yin P; Mao K; Zhang J
Cancer Med; 2023 Jun; 12(12):13167-13181. PubMed ID: 37102245
[TBL] [Abstract] [Full Text] [Related]
17. Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Fukushima T; Morimoto M; Kobayashi S; Ueno M; Uojima H; Hidaka H; Kusano C; Chuma M; Numata K; Tsuruya K; Arase Y; Kagawa T; Hattori N; Ikeda H; Watanabe T; Tanaka K; Maeda S
Oncologist; 2023 Jul; 28(7):e526-e533. PubMed ID: 37023703
[TBL] [Abstract] [Full Text] [Related]
18. Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study.
Wang L; Peng JL; Wu JZ
Medicine (Baltimore); 2023 Mar; 102(13):e33319. PubMed ID: 37000113
[TBL] [Abstract] [Full Text] [Related]
19. Short and long-term outcomes after minimally invasive liver resection for single small hepatocellular carcinoma: An analysis of 714 patients from the IGoMILS (Italian group of minimally invasive liver surgery) registry.
Giuliante F; Ratti F; Panettieri E; Mazzaferro V; Guglielmi A; Ettorre GM; Gruttadauria S; Di Benedetto F; Cillo U; De Carlis L; Dalla Valle R; Ferrero A; Santambrogio R; Ardito F; Aldrighetti L;
HPB (Oxford); 2023 Jun; 25(6):674-683. PubMed ID: 36922259
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients.
Han CL; Tian BW; Yan LJ; Ding ZN; Liu H; Mao XC; Tian JC; Xue JS; Tan SY; Dong ZR; Yan YC; Hong JG; Chen ZQ; Wang DX; Li T
Cancer Immunol Immunother; 2023 Jul; 72(7):1957-1969. PubMed ID: 36811662
[TBL] [Abstract] [Full Text] [Related]
[Next]
